跳至主要内容
临床试验/ACTRN12616000661471
ACTRN12616000661471
已完成
未知

MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: A randomised controlled trial

The George Institute for Global Health0 个研究点目标入组 156 人2016年5月20日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Coronary Heart Disease
发起方
The George Institute for Global Health
入组人数
156
状态
已完成
最后更新
6年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2016年5月20日
结束日期
待定
最后更新
6年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • Participants will be eligible if they have a confirmed diagnosis of coronary heart disease, including a prior diagnosis of myocardial infarction, stable or unstable angina, coronary revascularisation procedure or current admission with an acute coronary syndrome event or \>50% stenosis in at least one major vessel on the coronary angiogram. In addition, participants will have to meet the following criteria: 1\) be an adult (\> 18 years), 2\) own an active smartphone that operates with iOS or Android operating systems, 3\) have sufficient English skills, and 4\) provide written informed consent.

排除标准

  • Patients will be excluded if they already use a medication reminder app or other electronic reminder systems to help them adhere to their medication regimen, e.g. calendar alerts in their phones. In addition, smartphones that are not capable of downloading the apps, for example older Apple iPhones, such as iPhones 4, that operate with older iOS versions, will be excluded, as the basic app is only compatible with iOS version 7\.0 or later and the advanced app with iOS version 8\.0 or later.

结局指标

主要结局

未指定

相似试验